InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,447.87
(
-0.31%
)
US TECH 100
18,978.00
(
-1.19%
)
Dow Jones
39,411.21
(
0.67%
)
Brent Oil
85.16
(
-0.13%
)
Bitcoin
60,464.76
(
0.34%
)
Post# of 252337
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

rfj1862

Send PM Follow Ignore
Followers 39
Posts 1714
Boards Moderated 0
Alias Born 10/05/2005

rfj1862

Re: DewDiligence post# 52791

Monday, 09/24/2007 5:12:03 PM

Monday, September 24, 2007 5:12:03 PM

Post# of 252337
>A drug I’d cite as evidence of the toughness of selling to hospitals is Angiomax. It’s a fine drug, but it costs a lot more than heparin.<

Not a good example. Angiomax isn't competing against heparin. It is competing against the combination of heparin or LMWH and a glycoprotein IIb-IIIa inhibitor (primarily Integrilin and ReoPro).
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up